.I have only just started looking at IXC so apologies if this has already been discussed
IXC certainly looks undervalued but I am trying to understand its potential value in different scenarios.
IF IXC successfully repurposes its drug (Exenatide ?), and although this seems probable, it may take a "while". So what is to stop a generic from appearing within a few years of IXC's drug being approved and being a market success?
.I have only just started looking at IXC so apologies if this...
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28320 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 22452 | 2 |
View Market Depth
| Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable